Tarja Linnankivi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tarja Linnankivi has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ala-Mello Sirpa
Rinnekoti Foundation, Rehabilitation Home for Children, Espoo, Finland.
2 shared publications - Esa Kuusinen
Department of Pediatrics, Satakunta Hospital District, Pori, Finland.
2 shared publications - Ilari Scheinin
Department of Pathology, Haartman Institute, University of Helsinki, and Laboratory of Helsinki and Uusimaa University Hospital, Helsinki, Finland.
2 shared publications - Janna Saarela
Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland
2 shared publications - Kati Kristiansson
Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland
2 shared publications - Kristiina Avela
Väestöliitto, The Family Federation of Finland, Department of Medical Genetics, Helsinki, Finland
2 shared publications
Latest Publications
- Open Access
- 18 November 2014
- Published by Springer Nature in BMC Medical Genetics
- Vol. 15 (1) , 124
Erratum to: high-resolution SNP array analysis of patients with developmental disorder and normal array CGH result
- 18 November 2014
- Published by Springer Nature in BMC Medical Genetics
- Vol. 15 (1) , 124
Open AccessErratum to: high-resolution SNP array analysis of patients with developmental disorder and normal array CGH result
- 19 November 2012
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 158A (12) , 3119-3125
Neuroimaging and neurological findings in patients with hypochondroplasia and FGFR3 N540K mutation
Hypochondroplasia (HCH), an autosomal dominant skeletal dysplasia caused by mutations in the FGFR3 gene, has not been commonly associated with neurological problems. Temporal lobe dysgenesis associated with epilepsy was recently described in single patients. In this retrospective study, we assessed neurological and neuroimaging aspects of 13 FGFR3 (N540K) mutation verified HCH patients in Finland. Eight patients had neurocognitive difficulties, ranging from specific learning disorder (2/13) to mild intellectual disability (5/13) or global developmental delay (1/13). Six of 13 patients had a history of seizures or epilepsy. Eight patients had undergone MRI. They all had structural abnormalities consistent with temporal lobe dysgenesis. Six patients had peritrigonal white matter reduction, and 4 had abnormally shaped lateral ventricles. We recommend a close follow‐up of development in patients with HCH and a low threshold for neuroimaging.
- 19 November 2012
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 158A (12) , 3119-3125
Neuroimaging and neurological findings in patients with hypochondroplasia and FGFR3 N540K mutation
Hypochondroplasia (HCH), an autosomal dominant skeletal dysplasia caused by mutations in the FGFR3 gene, has not been commonly associated with neurological problems. Temporal lobe dysgenesis associated with epilepsy was recently described in single patients. In this retrospective study, we assessed neurological and neuroimaging aspects of 13 FGFR3 (N540K) mutation verified HCH patients in Finland. Eight patients had neurocognitive difficulties, ranging from specific learning disorder (2/13) to mild intellectual disability (5/13) or global developmental delay (1/13). Six of 13 patients had a history of seizures or epilepsy. Eight patients had undergone MRI. They all had structural abnormalities consistent with temporal lobe dysgenesis. Six patients had peritrigonal white matter reduction, and 4 had abnormally shaped lateral ventricles. We recommend a close follow‐up of development in patients with HCH and a low threshold for neuroimaging.
- Open Access
- 18 September 2012
- Published by Springer Nature in BMC Medical Genetics
- Vol. 13 (1) , 84
High-resolution SNP array analysis of patients with developmental disorder and normal array CGH results
Diagnostic analysis of patients with developmental disorders has improved over recent years largely due to the use of microarray technology. Array methods that facilitate copy number analysis have enabled the diagnosis of up to 20% more patients with previously normal karyotyping results. A substantial number of patients remain undiagnosed, however.
- 18 September 2012
- Published by Springer Nature in BMC Medical Genetics
- Vol. 13 (1) , 84
Open AccessHigh-resolution SNP array analysis of patients with developmental disorder and normal array CGH results
Diagnostic analysis of patients with developmental disorders has improved over recent years largely due to the use of microarray technology. Array methods that facilitate copy number analysis have enabled the diagnosis of up to 20% more patients with previously normal karyotyping results. A substantial number of patients remain undiagnosed, however.
- Open Access
- 19 September 2003
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 18 (4) , 414-419
18q− Syndrome: Brain MRI shows poor differentiation of gray and white matter on T2‐weighted images
Purpose: To study brain MRI findings in patients with 18q− syndrome and to correlate these findings with the results of the molecular breakpoint analysis.Materials and Methods: Brain MR images of 17 patients with 18q− syndrome were evaluated. Segregation analysis was performed with 15 microsatellite markers to determine the deletion breakpoints and whether the deletion included the myelin basic protein (MBP) gene.Results: One patient had an interstitial deletion of 18q which spared the MBP gene. He was the only one with normal brain MRI. All 16 patients with deletions including the MBP gene had abnormal white matter in MRI. The main finding was poor differentiation of gray and white matter on T2‐weighted images due to increased white matter signal intensity. In addition, measured signal intensity of the white matter was significantly increased in patients compared with controls.Conclusions: Poor differentiation of gray and white matter on T2‐weighted images is the most typical MRI finding of the 18q− syndrome. These results support the postulation that abnormal myelination in 18q− syndrome is due to haploinsufficiency at or near the MBP locus. J. Magn. Reson. Imaging 2003;18:414–419.
- 19 September 2003
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 18 (4) , 414-419
Open Access18q− Syndrome: Brain MRI shows poor differentiation of gray and white matter on T2‐weighted images
Purpose: To study brain MRI findings in patients with 18q− syndrome and to correlate these findings with the results of the molecular breakpoint analysis.Materials and Methods: Brain MR images of 17 patients with 18q− syndrome were evaluated. Segregation analysis was performed with 15 microsatellite markers to determine the deletion breakpoints and whether the deletion included the myelin basic protein (MBP) gene.Results: One patient had an interstitial deletion of 18q which spared the MBP gene. He was the only one with normal brain MRI. All 16 patients with deletions including the MBP gene had abnormal white matter in MRI. The main finding was poor differentiation of gray and white matter on T2‐weighted images due to increased white matter signal intensity. In addition, measured signal intensity of the white matter was significantly increased in patients compared with controls.Conclusions: Poor differentiation of gray and white matter on T2‐weighted images is the most typical MRI finding of the 18q− syndrome. These results support the postulation that abnormal myelination in 18q− syndrome is due to haploinsufficiency at or near the MBP locus. J. Magn. Reson. Imaging 2003;18:414–419.